GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SC Ropharma SA (BSE:RPH) » Definitions » Total Payout Ratio

SC Ropharma (BSE:RPH) Total Payout Ratio : 0.22 (As of Jun. 11, 2024)


View and export this data going back to 1997. Start your Free Trial

What is SC Ropharma Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

SC Ropharma's current Total Payout Ratio is 0.22.


SC Ropharma Total Payout Ratio Historical Data

The historical data trend for SC Ropharma's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SC Ropharma Total Payout Ratio Chart

SC Ropharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.20 0.22

SC Ropharma Semi-Annual Data
Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.21 0.19 0.10 0.42

Competitive Comparison of SC Ropharma's Total Payout Ratio

For the Pharmaceutical Retailers subindustry, SC Ropharma's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SC Ropharma's Total Payout Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, SC Ropharma's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where SC Ropharma's Total Payout Ratio falls into.



SC Ropharma Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

SC Ropharma's Total Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0 + -2.55) / 11.678
=0.22

SC Ropharma's Total Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0 + -1.77) / 4.209
=0.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SC Ropharma Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of SC Ropharma's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


SC Ropharma (BSE:RPH) Business Description

Traded in Other Exchanges
N/A
Address
Str. Iuliu Maniu Nr. 55, ETAJ 1, Brasow, ROU, 500091
SC Ropharma SA is engaged in the production, distribution, and Retail sale of pharmaceutical products in specialized stores. Its product portfolio comprises over 50 products in the form of tablets, powders, capsules, and syrups covering 21 therapeutic areas.

SC Ropharma (BSE:RPH) Headlines

No Headlines